Blackstone’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$370K Buy
+4,963
New +$348K ﹤0.01% 413
2025
Q4
– Sell
-20,361
Closed -$1.06M – 258
2025
Q3
$1.06M Buy
+20,361
New +$993K ﹤0.01% 195

Other funds holding BBIO

Blackstone's BBIO Position: Q2 2026 in Review

Blackstone opened a new position in BridgeBio Pharma (BBIO) in Q2 2026: 4,963 shares worth $370K. The stake represents ﹤0.01% of the portfolio and ranks #413 among its holdings. This is a return to the name: Blackstone previously reported a position in BBIO as recently as Q3 2025.

Blackstone first reported a position in BBIO in Q3 2025 and has held it in 2 quarters since. The position peaked at $1.06M in Q3 2025. 477 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Blackstone held 4,963 shares of BridgeBio Pharma worth $370K as of Q2 2026.
  • BridgeBio Pharma was a new Blackstone position in Q2 2026.
  • BridgeBio Pharma made up ﹤0.01% of Blackstone's portfolio in Q2 2026, its #413 holding.
  • Blackstone first reported a position in BridgeBio Pharma in Q3 2025 and has held it in 2 quarters since.
  • Blackstone's BridgeBio Pharma position peaked at $1.06M in Q3 2025.
  • 477 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Blackstone's 13F filing for Q2 2026, filed 14 Aug 2026.